Abstract Background: Glioblastoma (GBM) is the most common and most aggressive form of brain cancer. After surgery, radiotherapy is the mainstay of treatment for GBM patients. Unfortunately, the vast majority of GBM patients fail responding to radiotherapy because GBM cells remain highly resistant to radiation. Radiotherapy-induced DNA damage response may correlate with therapeutic resistance. Methods: Ionizing radiation (IR) was used to induce DNA damage. Cell proliferation and migration were detected by wound-healing, MTT and apoptosis assays. Dual-luciferase assays and Western blot analysis were performed to evaluate NF-κB activation and validate microRNA targets. Real-time PCR was used to study mRNA and microRNA levels. Results: IR-induced DNA damage activated NF-κB in GBM cells which promoted expression of IL-6, IL-8 and Bcl-xL, thereby contributing to cell survival and invasion. Knockdown SENP2 expression enhanced NF-κB essential modulator (NEMO) SUMOylation and NF-κB activity following IR exposure. miR-181b targets SENP2 and positively regulated NF-κB activity. Conclusion: NF-κB activation by DNA damage in GBM cells confers resistance to radiationinduced death.
DNA Damage-Induced NF-κB Activation in Human Glioblastoma Cells Promotes miR-181b Expression and Cell Proliferation

Introduction
Glioblastoma (GBM) is the most common malignant primary central nervous system tumor in adults. Despite significant progress has been made in radiation, chemotherapy, and targeted biologic therapy, outcomes remain poor [1, 2] . A reason why it is very difficult to treat GBM is therapeutic resistance [3, 4] . Nevertheless, the exact mechanisms of therapeutic resistance remain poorly understood.
the mentioned primers and the following primers: 5'-CCCTATGCCGTTGGGAAATGCAGG -3' (forward) and 5'-CCTGCATTTCCCAACGGCATAGGG -3' (reverse). SENP2 and NEMO were cloned into pcDNA3.0-Flag vector and SUMO was cloned into pXJ40-HA vector. Bay11-7082, broad-spectrum caspase inhibitor Z-VAD-FMK (sc-3067), mouse anti-HA (sc-7392), anti-p-IκBα (sc-8404), anti-Bcl-2 (C-2, sc-7382), anti-Bcl-xL(H-5, sc-8392), anti-IKKα/β (sc-7607) and anti-β-actin (C4; sc-47778) antibodies, and rabbit anti-SENP2 (H-300, sc-67075), anti-TAK1 (M-579, sc-7162) and anti-IκBα (C-21; sc-371) antibodies were purchased from Santa Cruz Biotechnology (CA, USA). The mouse anti-Flag (M2; F3165) antibody was purchased from Sigma (U.S.). Rabbit anti-CYLD (#4495), anti-p-IKKα(Ser 180)/IKKβ(Ser 181) (#2681) and anti-p-TAK1 (Ser412) (#9339) antibodies were purchased from Cell Signaling Technology (USA). miR-181b, miR-181b inhibitor (as-miR-181b), miR negative control (miR-NC), and siRNA oligonucleotides targeting SENP2 were chemically synthesized in RIBOBIO (Guangzhou, China). The sequences for SENP2 siRNAs were as follows: si-SENP2-1: 5'-GUACCGAAAGUUAUUGGAA dTdT-3'; si-SENP2-2: 5'-GGAGCCUGACCUAUCAGAA dTdT-3'; si-SENP2-3: 5'-GGACAAACCUAU CACAUUUdTdT-3'.
Cell transfection and radiation treatment
The plasmids, microRNAs or siRNAs were transfected into T98G or U87MG cells using Lipofectamine TM 2000 reagent according to the manufacturer's instructions (Invitrogen). To increase the knockdown efficiencies, the cells were transfected with control siRNAs or siRNAs against SENP2 for the second time after 24 h. The transfected cells were irradiated (GE 3000) at a dose rate of 2.0 Gy/min.
Immunofluorescence assay
For immunofluorescence, T98G or U87MG cells were grown on cover slips and irradiated with 5 Gy in the presence or absence of general caspase inhibitor z-VAD-FMK (20 μM). At 40 min post-treatment, the cells were washed with PBS, fixed in 4% paraformaldehyde for 20 min at room temperature and permeabilized with 0.2% Triton X-100 for 3 min. After blocking in 5% BSA for 30 min, the cells were incubated with antip-H2A.X (γ-H2A.X, #9718S) monoclonal antibody at 37°C for 40 min followed by washing with PBS and incubation with TRITC-conjugated or FITC-conjugated anti-rabbit IgG antibody for 40 min at 37°C. The cells were then observed under an Olympus confocal microscope. The fluorescence intensities of γ-H2A.X were measured with Olympus Confocal Software (FV10-ASW 2.0).
Wound-healing assay
Confluent cells were scratched with a sterile pipette tip and washed with PBS. Photographs were taken after incubation for 0 and 20 h. Relative cell migration distance was determined by measuring the wound width on the monolayer under a microscope (Leica). The results are presented as the percentage of wound as follows: percentage of wound = (wound width at the time of measurement/initial wound width) × 100.
Cell proliferation assay (MTT)
T98G cells were seeded in a 96-well plate and exposed to IR (5 Gy) or left untreated along with incubation with Bay-11(10 μM) for 4 h. At 12, 24 and 48 h post-treatment, cell viability was measured using the methylthiazolete-trazolium (MTT) method.
Apoptosis assay T98G cells were seeded in a 6-well plate and exposed to IR (5 Gy) or left untreated along with incubation with Bay-11for 4 h. After 20 h, the cells were washed, resuspended in the staining buffer, and examined with Annexin V FITC apoptosis detection kit (BD) according to the manufacturer's instructions. Stained cells were analyzed by fluorescence-activated cell sorting (BD FACScalibur TM ).
Dual-luciferase reporter assay
To detect NF-κB activity, T98G or U87MG cells were co-transfected with pNF-κB-Luc reporter plasmid and the internal control pRL-TK. At 28 hours post-transfection, the cells were irradiated with 0, 5 and 10 Gy for another 8 h. The cells were harvested, and luciferase activity was measured using the dual-luciferase reporter assay system (Promega, USA) according to the manufacturer's recommendations.
To determine whether miR-181b plays a direct role in repression of luciferase expression from the pRL-TK vector containing SENP2 3'-UTR sequence, T98G or U87MG cells were transfected with miR-181b 
Western blot analysis
Cell lysates were prepared using cell lysis buffer (Cell Signaling Technology). The extracted proteins were separated using SDS-PAGE and transferred to a PVDF membrane. After blocking, the membrane was incubated with the primary antibody overnight at 4°C. After washing three times with TBS-T, the membrane was incubated with a horseradish peroxidase-conjugated secondary antibody for 2 hours at room temperature. Bands were detected using enhanced chemiluminescence (Applygen, Beijing, China).
Immunoprecipitation (IP) assays
T98G cells were harvested and lysed in lysis buffer (1% Triton X-100, 150 mM NaCl, 20 mM Hepes, pH 7.5, 10% glycerol, 1 mM EDTA and protease inhibitors). Cell lysates were centrifuged and the supernatant was incubated with the primary antibody at 4°C for 2 hours. Protein G agarose beads (Sigma, U.S.) were then added, and the mixture was incubated at 4°C overnight. The beads were washed three times with lysis buffer, boiled in 2×SDS loading buffer for 5 minutes, and then analyzed by Western blotting.
Quantitative real-time PCR (qRT-PCR)
For mRNA analysis, total RNA was isolated from cells using TRIzol and then converted to first-strand cDNA using M-MLV reverse transcriptase (Promega, U.S.). Real-time PCR was conducted using SYBR premix Ex Taq II (Takara Co., LTD). The cycle conditions included an initial denaturation step at 95°C for 30 seconds followed by 40 cycles of amplification for 3 seconds at 95°C and 1 minute at 60°C. The housekeeping gene GAPDH was used as an internal control. The sequences of gene specific primers used for qRT-PCR were as follows [17, 24, 25] 
For the analysis of miR-181b expression, total RNA was poly(A)-tailed using miRcute miRNA firststrand cDNA synthesis kit and real-time PCR was conducted using miRcute miRNA qPCR Detection (SYBR Green) (TianGen Biotech Co., LTD, China) according to the manufacturer's instructions. U6 was used as an internal control. The cycle conditions included an initial denaturation step at 94°C for 120 seconds followed by 45 cycles of amplification for 20 seconds at 94°C and 34 seconds at 60°C. The 2 -ΔΔCT equation was used to calculate the relative levels of miRNA expression [26] . The sequences of gene specific primers used for qRT-PCR were as follows: miR-181b, 5' -GGCCGAACATTCATTGCTGTCGGTGGGT-3'; U6, 5' -CGCAAGGATGACACG CAAATTC-3'.
Statistical analysis
The results are presented as the mean ± S.D. of three independent experiments. Statistical comparisons were performed using SPSS 11.5. Parametrical data were compared using Student's t test. One-way ANOVA analysis was used to determine the difference between independent groups. P < 0.05 was denoted as statistically significant.
Results
Ionizing radiation (IR) activates NF-κB in human GBM cells
Human GBM cell lines T98G and U87MG were exposed to IR (5 Gy) to induce DNA damage. Immunofluorescence analysis of phosphorylation of H2AX (γ-H2AX), a biomarker of DNA damage induced by IR [27] , suggested that IR exposure caused DNA damage in GBM cells (Fig.1A) . To further confirm the increased γ-H2AX is due to an increase in IR-induced DNA damage rather than caspase cleavage-mediated DNA fragmentation which also induces phosphorylation of H2AX, T98G or U87MG cells were exposed to IR in the presence or absence of general caspase inhibitor z-VAD-FMK (20 μM). As shown in Fig. 1A , z-VAD-FMK treatment had no significant effect on the levels of γ-H2AX in IR-treated cells, suggesting that the increased phosphorylation of H2AX was induced by IR.
We then performed dual-luciferase reporter assays to explore whether IR-induced DNA damage promotes NF-κB activation in GBM cells. Luciferase assays showed that DNA damage significantly enhanced the activation of NF-κB reporter in both T98G and U87MG cells (Fig.1B) . Since DNA damage-dependent NF-κB activation is associated with the phosphorylation of IκBα and its subsequent ubiquitin-dependent degradation [14] , we examined IκBα phosphorylation and degradation at different time points post-IR. We found IκBα phosphorylation was activated in T98G and U87MG cells by IR. Consistently, the levels of IκBα were reduced upon IR exposure (Fig. 1C) . Given that TAK1 is upstream of IKK and IKK is upstream of IκBα in DNA damage-induced NF-κB activation signaling [14, 15] , we then analyzed IKK phosphorylation and TAK1 phosphorylation after IR exposure in both T98G and U87MG cells. As expected, both IKK phosphorylation and TAK1 phosphorylation were activated upon IR exposure (Fig. 1D) . Taken together, this evidence suggested IR treatment can effectively induce NF-κB activation in both T98G and U87MG cells.
Inhibition of NF-κB activity increases radiation sensitivity of T98G cells
As mentioned above, IR exposure can induce NF-κB activation in human GBM cells. We found that IR-induced NF-κB activity and IκBα phosphorlyation can be suppressed by IKK/IκBα inhibitor (Bay-11) ( Fig. 2A and B) , suggesting that IR treatment can induce NF-κB activation in a manner dependent on the activation of IKK. NF-κB activation has been Cell
associated with therapeutic resistance in multiple human malignancies [6] . Therefore, we examined the effects of IR-induced NF-κB on cell proliferation and apoptotic death in T98G cells. As shown in Fig. 2C , D, and E, IR treatment had no significant effect on invasion and proliferation of T98G cells. However, inhibition of NF-κB activity by Bay11 attenuated invasion (p<0.05) and proliferation (p<0.01) in T98G cells upon IR exposure. Because NF-κB is well known to promote cell survival via inhibiting apoptosis [11] , we reasoned that inhibition of NF-κB with Bay11 may enhance apoptosis in T98G cells. Indeed, treatment with Bay11 significantly increased apoptosis in T98G cells following IR exposure (Fig. 2F) . Together, these data suggested that DNA damage-induced NF-κB activation may play a critical role in modulating radioresistance in human GBM cells.
IR up-regulates NF-κB-dependent proinflammatory cytokines and anti-apoptotic genes expression in GBM cells
To further characterize the functional significance of activation of NF-κB signaling in cancer progress upon radiotherapy, we analyzed levels of NF-κB-dependent proinflammatory cytokines IL-6 and IL-8 and anti-apoptotic genes Bcl-2 and Bcl-xL in IR-treated T98G cells by qRT-PCR. As expected, IR treatment stimulated the transcription of IL-6, IL-8, Bcl-2 and Bcl-xL; and NF-κB inhibitor Bay11 attenuated IR-induced upregulation of IL-6, IL-8, Bcl-2 and Bcl-xL (Fig. 3A) . We also detected the protein levels of Bcl-2 and Bcl-xL in both T98G and U87MG cells. Bcl-xL, but not Bcl-2, was observed to be upregulated by IR and attenuated by 5 . miR181b targets SENP2 and e n h a n c e s IR-induced NF-κB activity.
(A) S e q u e n c e complementarity between miR181b and the 3 (Fig. 4A) . SENP2 is the primary SUMO protease that deSUMOylates NEMO and an inhibitor of constitutive NF-κB activation induced by DNA damage. We therefore wondered whether the observed alternation in NEMO SUMOylation in T98G cells upon IR exposure could be correlated with alternations of SENP2 expression. Western blots assays showed that the abundance of SENP2 was enhanced upon IR exposure at 2 h and reduced at 4 h post-IR, in contrast to NEMO SUMOylation seen in these cells (Fig. 4B) . We then intended to study the effects of SENP2 knockdown on IR-induced NEMO SUMOylation. To this end, three siRNAs against SENP2 (si-SENP2-1, -2 and -3) were synthesized and cotransfected respectively with Flag-SENP2 to T98G cells. As shown in Fig. 4C , all of these siRNAs decreased the expression of Flag-tagged SENP2 with si-SENP2-1 and si-SENP2-3 showing high knockdown efficiency. In the following experiments, to increase knockdown efficiency, the three siRNAs targeting SENP2 were transfected as a mixture and re-transfected after 24 h. Our results in Fig. 4D indicated that SENP2 knockdown increased the levels of NEMO SUMOylation upon IR exposure, confirming the negative regulatory roles of SENP2 on NEMO SUMOylation. Since NEMO SUMOylation is required for DNA damage-induced NF-κB activation and SENP2 inhibits NEMO SUMOylation, SENP2 knockdown should result in enhanced NF-κB activity. This was confirmed by NF-κB-Luc reporter assay. IR exposure induced strong NF-κB activity in both control siRNAs and si-SENP2 transfected T98G cells, and such activity was enhanced when endogenous SENP2 was knocked down (Fig. 4E) . Taken together, these results suggested SENP2 inhibited IR-induced NF-κB activation in human GBM cells by deSUMOylation of NEMO.
miR-181b increases IR-induced NF-κB activity by targeting SENP2
The results above indicate that SENP2 levels correlate with NF-κB activity in IR-treated cells. As the observation that SENP2 expression was induced upon IR exposure at 2 h and reduced at 4 h post-IR, we wonder whether the levels of SENP2 could be regulated by an inducible microRNA. To test this possibility, we first performed bioinformatics analysis to predict the microRNAs targeting SENP2. miR-181b was selected for the further study because it has been shown to target cylindromatosis (CYLD) that functions as a deubiquitinating enzyme to inhibit TAK1 and IKK activation in NF-κB signaling pathway [23] . Sequence complementarity between miR-181b and SENP2 gene 3'UTR was shown in Fig. 5A . We then confirmed whether miR-181b targeted SENP2. To this end, we cloned SENP2 3'UTR into the pRL-TK vector immediately downstream of the firefly luciferase gene to construct the SENP2-luc reporter plasmid. T98G or U87MG cells were transfected with SENP2-luc and pGL-3-control which used as an internal control, along with miR-181b or its negative control. miR-181b overexpression significantly decreased the luciferase activity of SENP-luc vector when compared with miR control in both T98G and U87MG cells (Fig. 5B) . We further investigated whether miR-181b regulated the protein levels of SENP2. T98G or U87MG cells were transfected with miR-181b or its negative control. The expression of SENP2 and the validated miR-181b target gene CYLD were detected with Western blotting using specific antibodies. We found both of the protein levels of SENP2 and CYLD were decreased by over expression of miR-181b in both T98G and U87MG cells (Fig. 5C ). To further confirm the direct targeting of SENP2 by miR-181b, we constructed SENP2-mut-luc vector that carrying the mutant SENP2 3'UTR. Dual-luciferase assay indicated that miR-181b can not suppress the luciferase activity of SENP-mut-luc when compared with miR control (Fig. 5D) . These results indicated that SENP2 was a direct target of miR-181b. To confirm the expression of miR-181b in GBM cells, we analyzed levels of miR-181b in T98G and U87MG cells with or without IR exposure by qRT-PCR through measuring mature miR-181b. As shown in Fig.5E , IR treatment significantly increased miR-181b expression, suggesting that miR-181b can be induced by DNA damage in human GBM cells. We then investigated the effects of miR-181b on NF-κB-mediated regulation of SENP2. T98G or U87MG cells were transfected with miR-181b inhibitor (as-miR-181b) or its negative control (as-miR-NC) followed by IR treatment or left untreated. The mRNA levels of SENP2 were then detected by qRT-PCR. As shown in Fig.5F , IR triggers the expression of SENP2, and suppression of miR-181b expression resulted in upregulation of IR-induced SENP2 expression, suggesting that miR-181b regulated directly SENP2 expression during IR exposure. To further investigate the functional consequence of enhanced expression of miR-181b in GBM cells upon IR exposure, we transfected T98G or U87MG cells with miR-181b inhibitor and performed NF-κB-Luc reporter assay. As shown in Fig. 5G , suppression of miR-181b expression inhibited IR-induced NF-κB activity. Therefore, miR-181b may function as a positive regulator on the feedback loop of NF-κB activation via targeting SENP2 in GBM cells when exposed to DNA damaging agents.
Discussion
Genotoxic treatment-induced NF-κB activation has been associated with acquired therapeutic resistance in some types of cancer [6, 28, 29] . Here, we provide evidence that IR-induced DNA damage enhanced NF-κB activity in human GBM cells. Increased NF-κB activation up-regulates anti-apoptotic genes and proinflammatory genes which may contribute to cancer progress. Furthermore, the oncogenic miR-181b is also induced by IR which functions as a positive regulator on NF-κB activation by targeting SENP2.
Our model for sustained NF-κB activity and how NF-κB contributes to acquired therapeutic resistance in human GBM cells upon IR exposure was present in Fig. 5H . Upon DNA damage, nuclear events trigger post-translational modifications of NEMO such as SUMOylation and ubiquitination. These modifications then mediate the activation of TAK1 and IKKα/β to promote NF-κB signaling [14] . Activated NF-κB up-regulates a cohort of genes involved in cell survival, proliferation and migration. Moreover, the increased NF-κB activation also promotes miR-181b transcription. miR-181b induction in turn enhances NF-κB activity through directly targeting SUMO protease SENP2 and deubiquitinating enzyme CYLD, thereby forming a positive feedback loop to drive NF-κB activation during IR exposure.
NF-κB has a dual function during tumorgenesis. In the early stages, the tightly regulated NF-κB induces cellular apoptosis in response to oncogene activation or cellular stress and hence functions as a tumor suppressor [6] . However, during tumor progression high levels of inflammatory cytokines in the microenvironment of a solid tumor or accumulated defects in the pathways regulating NF-κB will contribute to aberrant NF-κB activity [30, 31] . Aberrant activation of NF-κB promotes tumorigenesis through its ability to induce the expression of antiapoptotic genes such as Bcl-xL and Bcl-2, the cyclin protein Cyclin D1, cellular adhesion molecules such as ICAM-1 and VCAM-1 and chemokine receptors such as CXCR4 to promote tumor cell survival, proliferation, angiogenesis, invasion and metastasis, and hence functions as a tumor promoter [11, 32, 33] . In particular, aberrant NF-κB activation may confer resistance to chemotherapy drugs and ionizing radiation because NF-κB inhibits apoptosis which induced by these treatment to kill cancer cells. Thus, inhibition of NF-κB could represent a potentially exciting new therapy of cancer.
MicroRNAs play critical regulatory roles in oncogenesis. The development of most human cancers was observed to be associated with dysregulated miRNAs expression. miR181b has been shown to be down regulated in GBM. However, lower levels of miR-181b in glioblastoma were positively correlated with response to radiotherapy /temozolomide (TMZ) treatment in glioblastoma patients [34] . These observations suggested that the function of miR-181b may be unique, depending on the type of tumor and cellular context. A study presented by Iliopoulos et al indicated that STAT3, a transcription factor activated by IL-6, directly activated miR-21 and miR-181b. miR-21 and miR-181b inhibited PTEN and CYLD respectively, leading to increased NF-κB activity to switch inflammation to cancer [23] . Here, we observed that IR exposure can induce miR-181b expression. Based on the result that IR-induced NF-κB promoted IL-6 expression in GBM cells, we hypothesized that IL-6/ Stat3 pathway may play essential roles in up-regulation of miR-181b in GBM cells upon IR exposure. The detailed mechanism remained for further study. 
